PL-19 splanchnic vein thrombosis: New risk factors and management

Thrombosis Research

Volumn 129, Issue SUPPL. 1, 2012, Pages

  Donadini, Marco P ^a   Dentali, Francesco ^a   Ageno, Walter ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Myeloproliferative neoplasms; Risk factors; Splanchnic vein thrombosis

Indexed keywords

ANTIVITAMIN K; JANUS KINASE 2; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; CONFERENCE PAPER; HUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SPLANCHNIC NERVE; SPLANCHNIC VEIN THROMBOSIS; VEIN THROMBOSIS; ARTICLE; COMORBIDITY; EPIDEMIOLOGY; NEOPLASM; PREVALENCE; RISK MANAGEMENT; SPLENIC VEIN;

ANTICOAGULANTS; CAUSALITY; COMORBIDITY; FIBRINOLYTIC AGENTS; HUMANS; NEOPLASMS; PREVALENCE; RISK FACTORS; RISK MANAGEMENT; SPLENIC VEIN; VENOUS THROMBOSIS;

EID: 84862152485     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(12)70025-7     Document Type: Conference Paper

References (44)

1. R Rajani, T Melin, E Bjornsson, U Broome ì, P Sangfelt, A Danielsson et al. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience Liver Int 29 2009 253 259
2. R Rajani, S Almer Incidence and prevalence rates in Budd-Chiari syndrome Gut 57 2008 1469 1478
3. TP Almdal, TI Sorensen Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver Hepatology 13 1991 650 655
4. M Ögren, D Bergqvist, M Björck, S Acosta, H Eriksson, NH Sternby Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: A population study based on 23 796 consecutive autopsies World J Gastroenterol 12 2006 2115 2119
5. S Acosta, A Alhadad, P Svensson, O Ekberg Epidemiology, risk and prognostic factors in mesenteric venous thrombosis Br J Surg 95 2008 1245 1251
6. W Ageno, A Squizzato, A Togna, F Magistrali, M Mangini, C Fugazzola et al. Incidental diagnosis of deep vein thrombosis in consecutive patients undergoing a ct scan of the abdomen: a retrospective cohort study J Thromb Haemost 2011 in press.
7. MR Thatipelli, RD McBane, DO Hodge, WE Wysokinski Survival and Recurrence in Patients With Splanchnic Vein Thromboses Clin Gastroenterol Hepatol 8 2010 200 205
8. W Ageno, S Schulman, N Riva, S-M Bang, MT Sartori, J Beyer et al. International registry on splanchnic vein thrombosis: description of the study population J Thromb Haemost 9 Suppl 2 2011 304 [abstract].
9. S Darwish Murad, DC Valla, PC de Groen, G Zeitoun, JAM Hopmans, HB Haagsma et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome Hepatology 39 2004 500 508 (Pubitemid 38222192)
10. B Condat, F Pessione, S Hillaire, MH Denninger, MC Guillin, M Poliquin et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy Gastroenterology 120 2001 490 497 (Pubitemid 32147646)
11. A Plessier, S Darwish-Murad, M Hernandez-Guerra, Y Consigny, F Fabris, J Trebicka et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study Hepatology 51 2010 210 218
12. F Dentali, M Galli, M Gianni, W Ageno Inherited thrombophilic abnormalities and risk of portal vein thrombosis: a meta-analysis Thromb Haemost 99 2008 675 682 (Pubitemid 351694223)
13. A Squizzato, W Ageno, A Cattaneo, N Brumana A Case Report and Literature Review of Portal Vein Thrombosis Associated with Cytomegalovirus Infection in Immunocompetent Patients Clin Infect Dis 44 2007 e13 e16
14. N Hedayati, GM Riha, P Kougias, TT Huynh, C Cheng, C Bechara et al. Prognostic Factors and Treatment Outcome in Mesenteric Vein Thrombosis Vasc Endovascular Surg 42 2008 217 224 (Pubitemid 351852620)
15. F Dentali, W Ageno, D Witt, A Malato, N Clark, D Garcia et al. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: A multi-centre, retrospective cohort study Thromb Haemost 102 2009 501 504
16. DC Valla Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West J Gastroenterol Hepatol 19 2004 S204 S211
17. V De Stefano, I Martinelli Splanchnic vein thrombosis: clinical presentation, risk factors and tratment Intern Emerg Med 6 2010 487 494
18. JH Smalberg, MJ Kruip, HL Janssen, DC Rijken, FW Leebeek, MP de Maat Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences Arterioscler Thromb Vasc Biol 31 2011 485 493
19. R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders N Engl J Med 352 2005 1779 1790 (Pubitemid 40570926)
20. M Primignani, G Barosi, G Bergamaschi, U Gianelli, F Fabris, R Reati et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis Hepatology 44 2006 1528 1534 (Pubitemid 44953658)
21. D Colaizzo, L Amitrano, GL Tiscia, G Scenna, E Grandone, MA Guardascione et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis J Thromb Haemost 5 2007 55 61 (Pubitemid 44921067)
22. V De Stefano, A Fiorini, E Rossi, T Za, G Farina, P Chiusolo et al. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders J Thromb Haemost 5 2007 708 714 (Pubitemid 46563568)
23. F Dentali, A Squizzato, L Brivio, L Appio, L Campiotti, M Crowther et al. JAK2V617F mutation for the early diagnosis of Ph-negative myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis Blood 113 2009 5617 5623
24. F Dentali, A Squizzato, L Appio, L Brivio, W Ageno JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease J Thromb Haemost 7 2009 722 725
25. M Marchetti, A Falanga Leukocytosis, JAK2V617F mutation, and hemostasis in myeloproliferative disorders Pathophysiol Haemost Thromb 36 2008 148 159
26. SG Xavier, T Gadelha, SM Rezende, IR Zalcberg, N Spector JAK2V617F mutation in patients with thrombosis: to screen or not to screen? Int J Lab Hematol 33 2011 117 124
27. JJ Kiladjian, F Cervantes, FW Leebeek, C Marzac, B Cassinat, S Chevret et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases Blood 111 2008 4922 4929 15
28. AV Jones, A Chase, RT Silver, D Oscier, K Zoi, YL Wang et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms Nat Genet 41 4 2009 446 449
29. O Kilpivaara, S Mukherjee, AM Schram, M Wadleigh, A Mullally, BL Ebert et al. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms Nat Genet 41 4 2009 455 459
30. D Olcaydu, A Harutyunyan, R Jäger, T Berg, B Gisslinger, I Pabinger et al. common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms Nat Genet 41 4 2009 450 454
31. JH Smalberg, E Koehler, S Darwish Murad, A Plessier, S Seijo et al. The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis Blood 117 2011 3968 3973
32. E Kouroupi, JJ Kiladjian, C Chomienne, C Dosquet, S Bellucci, D Valla et al. The JAK2 46/1 haplotype in splanchnic vein thrombosis Blood 117 2011 5777 5778
33. C Parker, M Omine, S Richards, J Nishimura, M Bessler, R Ware et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria Blood 106 2005 3699 3709 (Pubitemid 41739003)
34. JH Smalberg, S Darwish Murad, E Braakman, PJ Valk, HL Janssen, FW Leebeek Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome Haematologica 91 2006 1712 1713 (Pubitemid 46032973)
35. J Hoekstra, FW Leebeek, A Plessier, S Raffa, S Darwish Murad, J Heller et al. Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study J Hepatol 51 2009 696 706
36. JC Garcia-Pagan, M Heydtmann, S Raffa, A Plessier, S Murad, F Fabris et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients Gastroenterology 135 2008 808 815
37. SK Sarin, JD Sollano, YK Chawla, D Amarapurkar, S Hamid, M Hashizume et al. Consensus on extra-hepatic portal vein obstruction Liver Int 26 2006 512 519
38. R De Franchis Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 43 2005 167 176 (Pubitemid 40805288)
39. C Kearon, SR Kahn, G Agnelli, S Goldhaber, GE Raskob, AJ Comerota, American College of Chest Physicians Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl 2008 454S 545S (Pubitemid 351892971)
40. L Amitrano, MA Guardascione, M Scaglione, L Pezzullo, N Sangiuliano, MF Armellino et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses Am J Gastroenterol 102 2007 2464 2470 (Pubitemid 47631782)
41. B Condat, F Pessione, M Helene Denninger, S Hillaire, D Valla Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy Hepatology 32 2000 466 470
42. A Tripodi, M Primignani, L Lemma, V Chantarangkul, A Dell'Era, F Iannuzzi et al. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method Hepatology 52 2010 249 255
43. A Tripodi, PM Mannucci The coagulopathy of chronic liver disease N Engl J Med 365 2011 147 156
44. N Riva, E Rancan, W Ageno, F Dentali Unmet clinical needs in the management of patients with splanchnic vein thrombosis Intern Emerg Med 5 2010 459 461